Flerie AB (publ) (OM: FLERIE)
Health Care · Pharmaceuticals · SE
Skr19.20
-4.00% today · -46.2% 1Y
Flerie AB (publ) (OM: FLERIE) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $182.34M and employs 2 people.
Over the last twelve months the share price has lost 46.2%, trading between 19.40 and 39.11.
Tweenvest scores Flerie AB (publ) across four factors: quality 40/100, value 65/100. Its strongest factor is value.
FLERIE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $182.34M
- Revenue (TTM)
- $-577.79K
- P/E
- —
- EPS
- -9.68
- Dividend yield
- —
- Beta (5Y)
- -0.43
- 52-week high
- Skr39.11
- 52-week low
- Skr19.40
- Avg volume (3M)
- —
- Shares outstanding
- 86.70M
- Employees
- 2
- Next earnings
- —
About Flerie AB (publ)
Flerie AB (publ) functions as a venture capital entity, concentrating its investments on nascent businesses. The firm actively seeks to fund biotechnology and pharmaceutical companies dedicated to advancing drug discovery and development, or producing innovative tools and applications aimed at addressing pressing global health concerns. Geographically, their investment scope includes Europe, the United States, and Israel. Founded in 2011, Flerie AB (publ) is headquartered in Stockholm, Sweden, and also operates a branch office in London, United Kingdom.
- ISIN
- SE0022447348
- Founded
- 2011
- Listed since
- Jun 11, 2024
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.